IMPACT BIOMEDICAL INC.
IBO · XNYSCIK 1834105fmd_0ZP5JY7KVJQCNZDF4PS8N593SMManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2022 to Sep 30, 2026, 18 periods
Latest annual · FY2025
Millions- Total revenues
- 0
- Gross profit
- (0)
- Operating income
- (4)
- Net income
- (12)
Latest quarter · Q3 FY2026
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (1)
- Net income
- (1)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2022 to FY2025
- -13.8%
IMPACT BIOMEDICAL INC. (IBO) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $32,000 | 10-K 2026-03-11 · proof | ||
| Gross profit | -$392,000 | 10-K 2026-03-11 · proof | ||
| Operating income | -$4.3 million | -$28.8 million | 10-K 2026-03-11 · proof | |
| Net income | -$11.8 million | -$24.7 million | 10-K 2026-03-11 · proof | |
| Cash from operating activities | -$1.9 million | -$2.9 million | 10-K 2026-03-11 · proof | |
| Total assets | $17.4 million | $20.3 million | -14.2% | 10-K 2026-03-11 · proof |
| Total liabilities | $1.9 million | $13.1 million | -85.8% | 10-K 2026-03-11 · proof |
| Cash and cash equivalents | $3,000 | $2 million | -99.8% | 10-K 2026-03-11 · proof |
- What was IMPACT BIOMEDICAL INC. (IBO)'s revenue in fiscal 2025?
- IMPACT BIOMEDICAL INC. (IBO) reported revenue of $32,000 for fiscal 2025 (the year ended Dec 31, 2025). Source: the 10-K filed with the SEC on Mar 11, 2026. SEC
- What was IMPACT BIOMEDICAL INC. (IBO)'s gross profit in fiscal 2025?
- IMPACT BIOMEDICAL INC. (IBO) reported gross profit of -$392,000 for fiscal 2025 (the year ended Dec 31, 2025). Source: the 10-K filed with the SEC on Mar 11, 2026. SEC
- What was IMPACT BIOMEDICAL INC. (IBO)'s operating income in fiscal 2025?
- IMPACT BIOMEDICAL INC. (IBO) reported operating income of -$4.3 million for fiscal 2025 (the year ended Dec 31, 2025), against -$28.8 million the year before. Source: the 10-K filed with the SEC on Mar 11, 2026. SEC
- What was IMPACT BIOMEDICAL INC. (IBO)'s net income in fiscal 2025?
- IMPACT BIOMEDICAL INC. (IBO) reported net income of -$11.8 million for fiscal 2025 (the year ended Dec 31, 2025), against -$24.7 million the year before. Source: the 10-K filed with the SEC on Mar 11, 2026. SEC
- What was IMPACT BIOMEDICAL INC. (IBO)'s cash from operating activities in fiscal 2025?
- IMPACT BIOMEDICAL INC. (IBO) reported cash from operating activities of -$1.9 million for fiscal 2025 (the year ended Dec 31, 2025), against -$2.9 million the year before. Source: the 10-K filed with the SEC on Mar 11, 2026. SEC
- What are IMPACT BIOMEDICAL INC. (IBO)'s total assets?
- As of Dec 31, 2025, IMPACT BIOMEDICAL INC. (IBO) reported total assets of $17.4 million, against $20.3 million a year earlier (-14.2%). Source: the 10-K filed with the SEC on Mar 11, 2026. SEC
- What are IMPACT BIOMEDICAL INC. (IBO)'s total liabilities?
- As of Dec 31, 2025, IMPACT BIOMEDICAL INC. (IBO) reported total liabilities of $1.9 million, against $13.1 million a year earlier (-85.8%). Source: the 10-K filed with the SEC on Mar 11, 2026. SEC
- What are IMPACT BIOMEDICAL INC. (IBO)'s cash and cash equivalents?
- As of Dec 31, 2025, IMPACT BIOMEDICAL INC. (IBO) reported cash and cash equivalents of $3,000, against $2 million a year earlier (-99.8%). Source: the 10-K filed with the SEC on Mar 11, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:IBO&period_type=annual&limit=5"Information only, not investment advice.